JP6243360B2 - 経鼻配送装置 - Google Patents
経鼻配送装置 Download PDFInfo
- Publication number
- JP6243360B2 JP6243360B2 JP2014558145A JP2014558145A JP6243360B2 JP 6243360 B2 JP6243360 B2 JP 6243360B2 JP 2014558145 A JP2014558145 A JP 2014558145A JP 2014558145 A JP2014558145 A JP 2014558145A JP 6243360 B2 JP6243360 B2 JP 6243360B2
- Authority
- JP
- Japan
- Prior art keywords
- delivery device
- delivery
- arm
- substance
- nasal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012384 transportation and delivery Methods 0.000 title claims description 106
- 239000000126 substance Substances 0.000 claims description 50
- 210000003928 nasal cavity Anatomy 0.000 claims description 11
- 239000007921 spray Substances 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 4
- 238000006073 displacement reaction Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 230000000881 depressing effect Effects 0.000 claims 1
- 210000001331 nose Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 description 14
- 229940079593 drug Drugs 0.000 description 12
- 239000000463 material Substances 0.000 description 7
- 210000000214 mouth Anatomy 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 210000002850 nasal mucosa Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 206010028735 Nasal congestion Diseases 0.000 description 4
- 239000000443 aerosol Substances 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 239000000850 decongestant Substances 0.000 description 3
- 229940124581 decongestants Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000001989 nasopharynx Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 206010033078 Otitis media Diseases 0.000 description 2
- 201000003462 adenoid hypertrophy Diseases 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 210000000613 ear canal Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000005828 hydrofluoroalkanes Chemical class 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000000492 nasalseptum Anatomy 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 208000001705 Mouth breathing Diseases 0.000 description 1
- 208000000592 Nasal Polyps Diseases 0.000 description 1
- 206010028741 Nasal inflammation Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010068956 Respiratory tract inflammation Diseases 0.000 description 1
- 208000028347 Sinus disease Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000002460 anti-migrenic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 208000001288 gastroparesis Diseases 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010226 intestinal metabolism Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 230000000420 mucociliary effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000010352 nasal breathing Effects 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012254 powdered material Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000012385 systemic delivery Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000001944 turbinate Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/08—Inhaling devices inserted into the nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0018—Details of inhalators; Constructional features thereof with exhalation check valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/002—Details of inhalators; Constructional features thereof with air flow regulating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
- A61M15/0098—Activated by exhalation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0618—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
- Medicinal Preparation (AREA)
Description
Claims (17)
- 物質を患者の鼻気道に配送する経鼻配送装置であって、
患者の鼻腔にフィットするノーズピースと、
前記患者が使用中に呼息するマウスピースと、
手動で変位されることにより、前記ノーズピースから物質を配送するよう配送ユニットを作動させる作動部を備える配送ユニットと、
前記ノーズピースおよび前記マウスピースと流体連通するバルブアセンブリと
を備え、
前記バルブアセンブリは、ボディ要素と、前記配送ユニットの前記作動部の手動の変位により閉構成と開構成との間を移動可能に前記ボディ要素に配置され、前記ノーズピースを通して物質配送と同時にエアフローを提供するバルブ要素とを備え、
前記ボディ要素がピボットを含み、
前記バルブ要素がアームを備え、
前記アームの一端が前記ボディ要素の前記ピボットに対し前記閉構成と前記開構成との間を枢動する、配送装置。 - 前記アームが少なくとも部分的に弾性である、
請求項1に記載の配送装置。 - 前記ボディ要素が、前記アームの他端がスライド可能なスライド面を含む、
請求項1または2に記載の配送装置。 - 前記アームが、第1アーム部分を備え、
前記第1アーム部分は、前記バルブ要素が前記閉構成にあるとき、該第1アーム部分が前記配送ユニットの前記作動部の変位により係合可能であるように構成されている、
請求項1〜3のいずれかに記載の配送装置。 - 前記アームが配送装置の長手方向軸に対し内向きに付勢されている、
請求項4に記載の配送装置。 - 前記バルブ要素が前記閉構成にあるとき、前記アームが、前記配送装置の前記長手方向軸に対し内向きに傾斜している、
請求項4または5に記載の配送装置。 - 前記第1アーム部分が実質的に剛性部分を備える、
請求項4〜6のいずれかに記載の配送装置。 - 前記アームが、前記ボディ要素の前記スライド面と係合する第2アーム部分を備える、
請求項4〜7のいずれかに記載の配送装置。 - 前記第1アーム部分と前記第2アーム部分が鈍角をなす、
請求項8に記載の配送装置。 - 前記第2アーム部分が、前記バルブ要素を前記閉構成に付勢する働きをする弾性部分である、
請求項8または9に記載の配送装置。 - 前記ボディ要素が、バルブ開口部を画定するバルブシートを含み、
前記バルブ要素が、前記バルブ要素が前記閉位置にあるとき前記バルブ開口部を閉じる働きをするシールを備える、
請求項1〜10のいずれかに記載の配送装置。 - 前記配送ユニットの前記作動部が貫通して延びる開口部を含むハウジングをさらに備える、
請求項1〜11のいずれかに記載の配送装置。 - 前記ハウジングが、前記作動部をスライド可能に受け、前記ハウジングの前記開口部から空気が流れるのを防ぐシール部材さらに備える、
請求項12に記載の配送装置。 - 前記配送ユニットが、前記ノーズピースを通じて物質が配送される出口ユニットと、前記出口ユニットに物質を配送するために作動可能な物質供給ユニットとを備える、
請求項1〜13のいずれかに記載の配送装置。 - 前記出口ユニットが、スプレーノズルを備える、
請求項14に記載の配送装置。 - 前記配送ユニットの前記作動部が、前記物質供給ユニットの物質収容チャンバを備える、
請求項14または15に記載の配送装置。 - 前記物質供給ユニットが、前記物質収容チャンバの押下により作動可能な機械的配送ポンプを備える、
請求項1〜16のいずれかに記載の配送装置。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261603095P | 2012-02-24 | 2012-02-24 | |
US61/603,095 | 2012-02-24 | ||
PCT/EP2013/053746 WO2013124491A1 (en) | 2012-02-24 | 2013-02-25 | Nasal delivery devices |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017112095A Division JP6802114B2 (ja) | 2012-02-24 | 2017-06-06 | 経鼻配送装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015511158A JP2015511158A (ja) | 2015-04-16 |
JP6243360B2 true JP6243360B2 (ja) | 2017-12-06 |
Family
ID=47915158
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014558145A Active JP6243360B2 (ja) | 2012-02-24 | 2013-02-25 | 経鼻配送装置 |
JP2017112095A Active JP6802114B2 (ja) | 2012-02-24 | 2017-06-06 | 経鼻配送装置 |
JP2020195861A Active JP7018497B2 (ja) | 2012-02-24 | 2020-11-26 | 経鼻配送装置 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017112095A Active JP6802114B2 (ja) | 2012-02-24 | 2017-06-06 | 経鼻配送装置 |
JP2020195861A Active JP7018497B2 (ja) | 2012-02-24 | 2020-11-26 | 経鼻配送装置 |
Country Status (17)
Country | Link |
---|---|
US (4) | US10300229B2 (ja) |
EP (4) | EP2817052B1 (ja) |
JP (3) | JP6243360B2 (ja) |
KR (1) | KR20150004327A (ja) |
CN (2) | CN104428025B (ja) |
AU (1) | AU2013223972B2 (ja) |
CA (1) | CA2865352C (ja) |
DK (2) | DK3281664T3 (ja) |
ES (3) | ES2847152T3 (ja) |
HK (2) | HK1207994A1 (ja) |
IN (1) | IN2014DN07609A (ja) |
MX (1) | MX352029B (ja) |
PL (1) | PL2817052T3 (ja) |
RU (1) | RU2640008C2 (ja) |
SG (2) | SG11201405178RA (ja) |
WO (1) | WO2013124491A1 (ja) |
ZA (1) | ZA201406597B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017164557A (ja) * | 2012-02-24 | 2017-09-21 | オプティノーズ アズ | 経鼻配送装置 |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0215270D0 (en) | 2002-07-02 | 2002-08-14 | Optinose As | Nasal devices |
GB0311570D0 (en) | 2003-05-20 | 2003-06-25 | Optinose As | Delivery device and method |
GB0319119D0 (en) | 2003-08-14 | 2003-09-17 | Optinose As | Delivery devices |
GB0320171D0 (en) | 2003-08-28 | 2003-10-01 | Optinose As | Delivery devices |
GB0420513D0 (en) | 2004-09-15 | 2004-10-20 | Optinose As | Powder delivery devices |
GB0503738D0 (en) | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
WO2007083073A1 (en) | 2006-01-19 | 2007-07-26 | Optinose As | Nasal administration |
GB0602980D0 (en) | 2006-02-14 | 2006-03-29 | Optinose As | Delivery device and method |
GB0604444D0 (en) | 2006-03-06 | 2006-04-12 | Optinose As | Nasal devices |
GB0605799D0 (en) | 2006-03-23 | 2006-05-03 | Optinose As | Nasal delivery devices |
GB2438834A (en) | 2006-06-08 | 2007-12-12 | Optinose As | Intranasal protein administration |
GB2440316A (en) | 2006-07-25 | 2008-01-30 | Optinose As | Nasal inhaler with scrubber |
GB0623732D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Powder delivery devices |
GB0623731D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Delivery device |
GB0623728D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Delivery devices |
GB2448193A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal delivery device |
GB2448183A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
GB0719299D0 (en) | 2007-10-03 | 2007-11-14 | Optinose As | Nasal delivery devices |
GB201015371D0 (en) | 2010-09-14 | 2010-10-27 | Optinose As | Nasal delivery |
US9949923B2 (en) | 2011-03-15 | 2018-04-24 | Optinose As | Nasal delivery |
CN104428024B (zh) | 2012-02-24 | 2018-06-01 | 奥普蒂诺斯公司 | 鼻部递送装置 |
MY170349A (en) | 2012-02-24 | 2019-07-22 | Optinose As | Nasal delivery devices |
US11554229B2 (en) | 2013-03-26 | 2023-01-17 | OptiNose Inc. | Nasal administration |
USD761951S1 (en) | 2013-05-23 | 2016-07-19 | Optinose As | Nosepiece unit |
EP2868334B1 (de) | 2013-11-05 | 2017-01-11 | Benedict Gerber | Nasendusche |
US9884148B2 (en) | 2014-05-30 | 2018-02-06 | Neilmed Pharmaceuticals, Inc. | Angular cap for dispensing liquids |
USD743020S1 (en) * | 2014-05-30 | 2015-11-10 | Ketan C. Mehta | Nasal rinse tip |
WO2016049082A1 (en) * | 2014-09-22 | 2016-03-31 | Mehta Ketan C | Angular cap for dispensing liquids |
CA2966797C (en) | 2014-11-19 | 2023-06-27 | Optinose As | A nosepiece for delivering substance to a nasal cavity of a subject |
FR3046553B1 (fr) * | 2016-01-07 | 2018-02-16 | Aptar France Sas | Ensemble de distribution nasale de produit fluide. |
US11752280B2 (en) * | 2016-11-06 | 2023-09-12 | Microbase Technology Corp. | Apparatus for pressurized liquid transfusion |
WO2020005910A1 (en) * | 2018-06-28 | 2020-01-02 | Sandler Scientific, Llc | Sino-nasal rinse delivery device with agitation, flow-control and integrated medication management system |
WO2020070321A2 (en) | 2018-10-04 | 2020-04-09 | Optinose As | Exhalation delivery system for and method of treating sinus disease |
MX2022009050A (es) | 2020-01-22 | 2022-10-27 | Seelos Therapeutics Inc | Reduccion de los efectos secundarios de los antagonistas de nmda. |
USD959279S1 (en) | 2020-04-07 | 2022-08-02 | VB Brands LLC | Spray bottle |
WO2022241214A1 (en) | 2021-05-14 | 2022-11-17 | Seelos Therapeutics, Inc. | Methods of using nmda receptor antagonists |
TW202310825A (zh) | 2021-05-14 | 2023-03-16 | 美商西羅斯醫療公司 | 減少nmda受體拮抗劑之副作用 |
CN113616886B (zh) * | 2021-08-19 | 2023-04-28 | 艾特申博(苏州)医药科技有限公司 | 一种鼻腔给药干粉递送装置 |
CN115282412B (zh) * | 2022-01-14 | 2023-08-25 | 温州医科大学 | 经鼻腔进入血循环的给药装置及其应用方法 |
US11701479B1 (en) * | 2022-02-01 | 2023-07-18 | Green Sky Creations LLC | Systems, devices, and methods for administering cannabinoid mixtures |
CN118236614B (zh) * | 2024-03-26 | 2024-10-29 | 苏州新劢德医疗器械科技有限公司 | 一种流体递送装置 |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US605436A (en) | 1898-06-07 | Inhaler | ||
US642748A (en) | 1899-02-23 | 1900-02-06 | Arthur Manners | Inhaler. |
US658436A (en) | 1900-05-28 | 1900-09-25 | Hans Hennerich Groth | Insufflator. |
US746749A (en) | 1903-03-18 | 1903-12-15 | George E Seidel | Nasal medicator. |
US794641A (en) | 1905-03-06 | 1905-07-11 | Alfred H Ramey | Inhaler. |
US902832A (en) | 1907-09-20 | 1908-11-03 | Edward F Philbrook | Inhaler. |
US3636949A (en) * | 1969-08-08 | 1972-01-25 | Armstrong Kropp Dev Corp | Inhalation-initiated aerosol dispenser |
US5297542A (en) | 1989-06-22 | 1994-03-29 | Raymond J. Bacon | Aerosol dispensing device |
ES2302332T3 (es) | 1994-09-21 | 2008-07-01 | Nektar Therapeutics | Aparato y metodos para dispersar medicamentos en polvo seco. |
NZ298384A (en) | 1995-01-23 | 1998-07-28 | Direct Haler As | Inhaler - single dose of particulate substance arranged in air flow passage |
US5797392C1 (en) | 1996-01-22 | 2001-01-09 | Direct Haler As | Inhaler |
SI0986413T1 (en) * | 1997-05-27 | 2004-12-31 | Direct-Haler A/S | Inhaler for powdered medicaments |
GB0114272D0 (en) | 2001-06-12 | 2001-08-01 | Optinose As | Nasal delivery device |
EP3124067A3 (en) | 1999-03-03 | 2017-05-24 | Optinose AS | Nasal delivery device |
GB0121568D0 (en) | 2001-09-06 | 2001-10-24 | Optinose As | Nasal delivery device |
GB0015309D0 (en) | 2000-06-21 | 2000-08-16 | Djupesland Per G | Apparatus |
ZA200306564B (en) | 2001-02-26 | 2004-10-15 | Optinose As | Nasal devices. |
GB0207422D0 (en) | 2002-03-28 | 2002-05-08 | Optinose As | Nasal devices |
GB0207817D0 (en) | 2002-04-04 | 2002-05-15 | Optinose As | Nasal devices |
GB0209494D0 (en) | 2002-04-25 | 2002-06-05 | Optinose As | Nasal devices |
GB0215270D0 (en) | 2002-07-02 | 2002-08-14 | Optinose As | Nasal devices |
GB0215904D0 (en) | 2002-07-09 | 2002-08-21 | Team Holdings Uk Ltd | Drug delivery system and method |
GB0300008D0 (en) | 2003-01-02 | 2003-02-05 | Optinose As | Delivery devices |
GB0311570D0 (en) | 2003-05-20 | 2003-06-25 | Optinose As | Delivery device and method |
GB0319119D0 (en) | 2003-08-14 | 2003-09-17 | Optinose As | Delivery devices |
GB0320171D0 (en) | 2003-08-28 | 2003-10-01 | Optinose As | Delivery devices |
USD530815S1 (en) | 2004-03-19 | 2006-10-24 | Optinose As | Nasal delivery device |
GB0420513D0 (en) | 2004-09-15 | 2004-10-20 | Optinose As | Powder delivery devices |
GB0503738D0 (en) | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
US20060289006A1 (en) * | 2005-06-27 | 2006-12-28 | Kos Life Sciences, Inc. | Breath actuated nasal drug delivery system |
WO2007083073A1 (en) | 2006-01-19 | 2007-07-26 | Optinose As | Nasal administration |
EP1988953B1 (en) | 2006-02-14 | 2017-07-19 | Optinose AS | Delivery device |
GB0602980D0 (en) | 2006-02-14 | 2006-03-29 | Optinose As | Delivery device and method |
GB0604319D0 (en) | 2006-03-03 | 2006-04-12 | Optinose As | Nasal delivery |
GB0604444D0 (en) | 2006-03-06 | 2006-04-12 | Optinose As | Nasal devices |
GB0605799D0 (en) | 2006-03-23 | 2006-05-03 | Optinose As | Nasal delivery devices |
GB2437488A (en) | 2006-04-25 | 2007-10-31 | Optinose As | Pharmaceutical oily formulation for nasal or buccal administration |
GB2438834A (en) | 2006-06-08 | 2007-12-12 | Optinose As | Intranasal protein administration |
GB2440316A (en) | 2006-07-25 | 2008-01-30 | Optinose As | Nasal inhaler with scrubber |
CA2662322A1 (en) * | 2006-09-06 | 2008-03-13 | Abbott Respiratory Llc | Variable dose aerosol drug canister |
US7779841B2 (en) * | 2006-11-13 | 2010-08-24 | Carefusion 2200, Inc. | Respiratory therapy device and method |
GB0623732D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Powder delivery devices |
GB0623731D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Delivery device |
GB0623728D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Delivery devices |
US20100199984A1 (en) * | 2007-04-02 | 2010-08-12 | Abbott Laboratories | Breath actuated nasal pump |
GB2448183A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
GB2448193A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal delivery device |
GB0719299D0 (en) | 2007-10-03 | 2007-11-14 | Optinose As | Nasal delivery devices |
GB2471973B (en) | 2007-10-03 | 2012-03-14 | Optinose As | Nasal delivery devices |
EP2222411B1 (en) | 2007-11-29 | 2013-10-09 | Glaxo Group Limited | A dispensing device |
CA2715302A1 (en) * | 2008-02-15 | 2009-08-20 | Timothy Sean Immel | Aerosol therapy device with high frequency delivery |
US20110318345A1 (en) | 2008-09-15 | 2011-12-29 | Optinose As | Nasal delivery |
GB201015371D0 (en) | 2010-09-14 | 2010-10-27 | Optinose As | Nasal delivery |
US9949923B2 (en) | 2011-03-15 | 2018-04-24 | Optinose As | Nasal delivery |
DK3281664T3 (da) * | 2012-02-24 | 2021-01-25 | Optinose As | Nasale indgivelsesindretninger |
CN104428024B (zh) | 2012-02-24 | 2018-06-01 | 奥普蒂诺斯公司 | 鼻部递送装置 |
MY170349A (en) | 2012-02-24 | 2019-07-22 | Optinose As | Nasal delivery devices |
US11554229B2 (en) | 2013-03-26 | 2023-01-17 | OptiNose Inc. | Nasal administration |
BR112015024869A8 (pt) | 2013-03-26 | 2019-12-17 | Optinose As | uso de um agente terapêutico e/ou de diôxido de carbono para tratar um paciente e aparelhos e métodos para tratar terapeuticamente um paciente |
USD761951S1 (en) | 2013-05-23 | 2016-07-19 | Optinose As | Nosepiece unit |
USD725769S1 (en) | 2013-05-23 | 2015-03-31 | Optinose As | Nasal delivery device |
USD723156S1 (en) | 2013-05-23 | 2015-02-24 | Optinose As | Nasal delivery device |
CA2966797C (en) | 2014-11-19 | 2023-06-27 | Optinose As | A nosepiece for delivering substance to a nasal cavity of a subject |
-
2013
- 2013-02-25 DK DK17190469.1T patent/DK3281664T3/da active
- 2013-02-25 PL PL13711300T patent/PL2817052T3/pl unknown
- 2013-02-25 JP JP2014558145A patent/JP6243360B2/ja active Active
- 2013-02-25 IN IN7609DEN2014 patent/IN2014DN07609A/en unknown
- 2013-02-25 ES ES17190469T patent/ES2847152T3/es active Active
- 2013-02-25 CN CN201380021180.5A patent/CN104428025B/zh active Active
- 2013-02-25 MX MX2014010144A patent/MX352029B/es active IP Right Grant
- 2013-02-25 AU AU2013223972A patent/AU2013223972B2/en active Active
- 2013-02-25 CA CA2865352A patent/CA2865352C/en active Active
- 2013-02-25 EP EP13711300.7A patent/EP2817052B1/en active Active
- 2013-02-25 ES ES13711300.7T patent/ES2650926T3/es active Active
- 2013-02-25 ES ES20207667T patent/ES2983560T3/es active Active
- 2013-02-25 WO PCT/EP2013/053746 patent/WO2013124491A1/en active Application Filing
- 2013-02-25 SG SG11201405178RA patent/SG11201405178RA/en unknown
- 2013-02-25 RU RU2014138493A patent/RU2640008C2/ru active
- 2013-02-25 SG SG10201600092UA patent/SG10201600092UA/en unknown
- 2013-02-25 EP EP24182327.7A patent/EP4406572A3/en active Pending
- 2013-02-25 EP EP17190469.1A patent/EP3281664B8/en active Active
- 2013-02-25 KR KR20147026652A patent/KR20150004327A/ko not_active Application Discontinuation
- 2013-02-25 CN CN201710131575.0A patent/CN107569752B/zh active Active
- 2013-02-25 DK DK13711300.7T patent/DK2817052T3/da active
- 2013-02-25 EP EP20207667.5A patent/EP3799909B1/en active Active
- 2013-02-25 US US14/380,827 patent/US10300229B2/en active Active
-
2014
- 2014-09-09 ZA ZA2014/06597A patent/ZA201406597B/en unknown
-
2015
- 2015-06-30 HK HK15106223.9A patent/HK1207994A1/xx unknown
-
2017
- 2017-06-06 JP JP2017112095A patent/JP6802114B2/ja active Active
-
2018
- 2018-07-26 HK HK18109706.6A patent/HK1250225A1/zh unknown
- 2018-10-12 US US16/093,174 patent/US11033696B2/en active Active
-
2020
- 2020-11-26 JP JP2020195861A patent/JP7018497B2/ja active Active
-
2021
- 2021-05-11 US US17/316,779 patent/US20210290867A1/en not_active Abandoned
-
2024
- 2024-02-21 US US18/582,740 patent/US20240316297A1/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017164557A (ja) * | 2012-02-24 | 2017-09-21 | オプティノーズ アズ | 経鼻配送装置 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6243360B2 (ja) | 経鼻配送装置 | |
US20220096763A1 (en) | Nasal delivery | |
US20220347092A1 (en) | Nasal delivery | |
US20210220262A1 (en) | Nasal delivery | |
JP6382723B2 (ja) | 経鼻配送装置 | |
US8511303B2 (en) | Nasal delivery devices | |
EP1988953B1 (en) | Delivery device | |
US20140166008A1 (en) | Nasal delivery | |
WO2003020350A1 (en) | Nasal delivery device | |
GB2459266A (en) | Nasal delivery devices | |
JP2015507990A (ja) | 経鼻配送装置 | |
JP2010012291A (ja) | 経鼻装置 | |
WO2004060433A2 (en) | Delivery devices | |
GB2391482A (en) | Nasal delivery devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151109 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160223 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20161128 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161206 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170301 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170502 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170606 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20171017 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171109 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6243360 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |